
Cambrian Biopharma: A DisCo advancing modern healthcare with breakthrough medicines to enhance healthspan and quality of life.
Cambrian Biopharma is a clinical-stage drug development company focused on modernizing healthcare by creating therapeutics that extend healthspan, the period of life spent in good health. As a Distributed Development Company (DisCo), Cambrian advances multiple scientific breakthroughs targeting biological drivers of aging. Their approach involves developing interventions to treat specific diseases first, then deploying them as preventative medicines to enhance overall quality of life.
Cambrian Biopharma has partnered with exceptional scientists to harness advancements in aging biology, aiming to redefine healthcare by treating and ultimately preventing chronic diseases. The company has made significant progress in understanding mechanisms that change with age, positioning itself as a leader in developing future medicines.

Rejuveron Life Sciences
rejuveron.com

Retro Biosciences
retro.bio

Regenerative Bio
regen-bio.us

BioAge Labs
bioagelabs.com

Continuum Biosciences

Juvenescence
juvlabs.com

Generian Pharmaceuticals
generian.com

TenSixteen Bio

Repair Biotechnologies

Ampersand Biomedicines
ampersand.bio

Oisin Biotechnologies
oisinbio.com

Underdog Pharmaceuticals
cyclaritytx.com

AgeX Therapeutics

ABio-X
abio-x.com

Rubedo Life Sciences
rubedolife.com
Companies similar to Cambrian BioPharma include Rejuveron Life Sciences, Retro Biosciences, Regenerative Bio and BioAge Labs.
Cambrian BioPharma was founded in 2019.
Cambrian BioPharma's headquarters is located in New York City, NY, US.
As of Jul 26, 2023, Cambrian BioPharma has raised a total of $160M (USD).
Cambrian BioPharma has 30 employees as of Feb 5, 2024.